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Abstract
To evaluate the presence of components of a putative Intracellular Lactate Shuttle (ILS) in neurons, we attempted to
determine if monocarboxylate (e.g. lactate) transporter isoforms (MCT1 and -2) and lactate dehydrogenase (LDH) are
coexpressed in neuronal mitochondria of rat brains. Immunohistochemical analyses of rat brain cross-sections showed
MCT1, MCT2, and LDH to colocalize with the mitochondrial inner membrane marker cytochrome oxidase (COX) in cortical,
hippocampal, and thalamic neurons. Immunoblotting after immunoprecipitation (IP) of mitochondria from brain
homogenates supported the histochemical observations by demonstrating that COX coprecipitated MCT1, MCT2, and
LDH. Additionally, using primary cultures from rat cortex and hippocampus as well as immunohistochemistry and
immunocoprecipitation techniques, we demonstrated that MCT2 and LDH are coexpressed in mitochondria of cultured
neurons. These findings can be interpreted to mean that, as in skeletal muscle, neurons contain a mitochondrial lactate
oxidation complex (mLOC) that has the potential to facilitate both intracellular and cell-cell lactate shuttles in brain.
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Introduction
Lactate is produced continuously under fully aerobic conditions
in mammalian skeletal muscle, especially during exercise when
rates of glycogenolysis and glycolysis are elevated [1,2]. In addition
to lactate production, working skeletal muscles are also capable of
lactate removal, mainly via oxidation [3,4]. Consequently, the
lactate shuttle concept has been postulated to contain both cell-cell
[5] and intracellular components [1].
The concept of lactate shuttles as means to distribute potential
energy and provide a redox signaling mechanism within and
among cells [6] has been extended to the field of neuroscience
[7,8,9]. The astrocyte-neuron lactate shuttle hypothesis (ANLS)
posits that lactate is an essential element of neuron-glia metabolic
interactions [8,10]. Due to the ready accessibility to the
vasculature and the feasibility of muscle biopsy techniques, the
presence of a Cell-Cell Lactate Shuttle (CCLS) [6] has been
extensively supported in the periphery [1,11]. However, limited
access to the cerebral circulation and limited capacity for tissue
sampling has made evaluation of lactate shuttling within and
among brain cells difficult. Still, with current technologies it is
possible to evaluate components of Cell-Cell and Intracellular
Lactate Shuttles in brain. In the present study, we attempted to
determine if a Mitochondrial Lactate Oxidation Complex
(mLOC) exists in rat brain as it does in rodent [12,13] and
human [14] skeletal muscle. By using confocal laser scanning
microscopy (CLSM) and immunoblotting after immunoprecipita-
tion from cell lysates, we demonstrated that MCT1, MCT2, and
LDH are located in neuronal mitochondria, and additionally that
MCTs and LDH are associated with cytochrome oxidase (COX)
in rat brain mitochondria.
Methods
Materials
Aprotinin, DTT, EDTA, EGTA, HEPES, Leupeptin, Mops,
Nonidet P-40 (NP-40), Pepstatin A, PMSF, Sucrose, Tris, cytosine-b-
D-arabinofuranoside (Ara-C), and e-aminocaproic acid were pur-
chased from Sigma-Aldrich (St. Louis, MO). NaCl and NaN3 were
purchased from Fisher (Fairlawn, NJ). Na4P2O7?10 H2Ow a s
purchased from Matheson Coleman & Bell (Norwood, OH). Tissue
culture reagents were purchased from Invitrogen (Grand Island, NY).
Animal care and tissue sampling
The University of California, Berkeley ACUC approved all
protocols. Female Wistar rats (200–250 g) were fed and housed
under standard conditions. Animals were anesthetized via
pentobarbital sodium injection (50 mg/kg ip). For biochemistry,
whole brains were dissected, immediately frozen in liquid nitrogen,
ground into powder, and stored at 280uC until analysis. For
immunohistochemistry, rats were anesthetized and intracardially
perfused with 500 ml of normal saline at room temperature,
followed by 500 ml of ice-cold, freshly made 4% paraformalde-
hyde in phosphate buffer (PB, 0.1 M, pH 7.4). For immunolabel-
ing, brains were removed, post-fixed for 4 hours in 4%
paraformaldehyde at 4uC and then cryoprotected in 20% sucrose
at 4uC for at least 1 day; sections (40 mm) were cut on a microtone
and collected in cold PB.
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Primary hippocampus and cortex neuron-glia cultures were
prepared from the brains of embryonic day-18 Wistar rats as
previously described [15,16]. Brains were removed aseptically and
the hippocampus and cortex were dissected. After removing blood
vessels and meninges, hippocampal and cortical tissues were
dissociated by mild mechanical trituration in ice-cold calcium- and
magnesium-free Hank’s balanced salt solution (HBSS) with
10 mM HEPES and 20 mM glucose, pH 7.4. Cells were freed
by digestion in a papain solution (100 U/10 ml) for 20 min and
the reaction was stopped by adding 10% horse serum. After
pelleting by centrifugation, cells from the two brain areas were
resuspended and plated (1.5 10
5/1 ml medium/well) to 24-well
cell culture plates or (7.0 10
5/10 ml medium/dish) to 10 cm dishes
precoated with poly-L-lysine (500 mg/ml). The minimum essential
culture medium was supplemented with 5.4% (not heat-inactivat-
ed) fetal bovine serum (FBS), 0.1% serum extender, and 23 mM
glucose. Separate cultures derived from hippocampus and cortex
were maintained at 37uC in a humidified atmosphere of 5% CO2,
95% air. Seven days later, 1 ml/ml cytosine-b-D-arabinofurano-
side (Ara-C) with fresh Neurobasal media (with 2% B27
supplement and 25% Glutamax) was added to the cultures. Cell
harvesting for immunohistochemistry and other procedures was
conducted days 10–14.
Immunohistochemical analyses
For immunolabeling, rat brain cross-sections were pretreated in
50% ethanol and incubated in 10% normal donkey serum for
40 minutes. For immunolabeling, primary cells were fixed with ice-
cold acetone for 5 min and then permeabilized with 0.2% Triton X-
100 in PBS for 5 min. Thereafter, sections or primary cells were
incubated overnight at 4uC with rabbit anti-MCT1 (Brooks, custom
antibody), rabbit anti-MCT2 (Chemicon International, Temecula,
CA), mouse anti-cytochrome oxidase subunit IV (COX: Abcam,
Cambridge, MA), rabbit anti-voltage-dependent anion channel
(VDAC: Abcam), mouse anti-LDH H or M (Sigma-Aldrich, St.
Louis, MO), goat or rabbit anti-LDH (Abcam), chicken anti-
microtubule-associated protein (MAP2: Abcam), mouse anti-neuron
specific betaIIITublin(Tuj1: Covance), or chickenanti-glialfibrillary
acidicprotein(GFAP:Abcam).Invivo,thefiveisoformsofLDHexist
as combinations of two subtypes: H (predominant in heart) and M
(predominant in liver and skeletal muscle), encoded by two different
genes. The M (also known as A or 5) subunit is encoded on
chromosome 11p15.4, whereas the H (aka B or 1) subunit is encoded
on chromosome 12p12.2-p12.1. For clarity we shall use ‘‘H’’ and
‘‘M’’ terminology as it has some meaning for tissue LDH isoform
expression in nature. Anti-rabbit secondary antibodies conjugated to
AlexaFluor 488 were used for MCT1, MCT2, and VDAC detection.
Anti-goat Alexa Fluor 546 secondary antibodies (Molecular Probes)
were used for LDHdetection.ForCOX,anti-mouse Cy3 (Chemicon
International) was used. Anti-chicken Cy5 (Abcam) was used for
MAP2 detection. Anti-chicken Alexa Fluor 488 (Molecular Probes)
was used for GFAP detection. Secondary antibodies were incubated
for 1 hr at room temperature. Confocal laser scanning microscopy
(CLSM:Zeiss510META)wasusedforimmunofluorescentdetection
of cellular localizations of the mitochondrial reticulum (COX,
VDAC), MCT1, MCT2 and LDH as previously described [13].
Antibody staining was detected at an emission of 500–530 nm, 550–
600 nm, and 640–720 nm, after excitation at 488 nm, 543 nm, and
630 nm, respectively. An oil immersion objective (Zeiss 406/1.3
N.A. or 636/1.4 N.A.) was used to visualize stained sections. Images
represent optical slices of ,1.1 mm, and laser power and detection
gains were set such that signals from single-stained controls would not
appear in adjacent channels.
Preparation of subcellular fractions
After harvesting with PBS, primary cells were collected by
centrifuging at 700 g for 10 min at 4uC. Primary cells or
powdered brain tissues were gently homogenized in buffer A
(250 mM Sucrose, 5 mM NaN3, 2 mM EGTA, 100 mM PMSF,
1 mM Pepstatin A, 10 mM Leupeptin, 20 mM HEPES-Na,
pH 7.4) using a loose-fitting Dunce (Teflon-glass) homogenizer,
and then centrifuged at 600 g for 10 min at 4uC to remove
nuclei, debris, and unbroken cells. The supernatant was
centrifuged at 10,000 g for 30 min at 4uC to precipitate
mitochondria. The pellet from this high-speed spin was washed
in buffer B (1 mM EDTA and 10 mM Tris, pH 7.4) and then
resuspended in 200 mL of buffer C (10 mM Tris, 1 mM EDTA,
150 mM NaCl, and 10 mg/ml aprotinin, pH 7.4) with 4% SDS
and centrifuged at room temperature at 1,100 g for 20 min. This
supernatant was used for immunoblots of mitochondrial (MI)
fraction. The rest of the mitochondrial pellet was washed three
times in buffer B and resuspended in 500 mL of buffer C with
0.3–1% Tween 20; this mitochondrial fraction was used for
immunoprecipitation (IP).
Immunoprecipitation (IP)
Immunoprecipitation was conducted as previously described
[13]. Agarose-conjugated protein G (Santa Cruz Biotechnology)
was added to the mitochondrial fractions and incubated at 4uC for
30 min. Samples were centrifuged at 2300 g and 4uC for 1 min
and aliquots of the supernatant were reacted with primary
antibodies to COX and rat normal IgG (Santa Cruz) at 4uC for
overnight. Then, agarose-conjugated protein G was added and
incubated at 4uC for 1 hr. The pellet was collected by
centrifugation at 2300 g at 4uC for 1 min. The supernatant
(lysate) was used for SDS-PAGE. The pellet was washed 3 times by
PBS buffer (pH 7.4) and 1 time by buffer C. The final pellet from
immunoprecipitation (IP) was used for SDS-PAGE.
Immunoblots (IB)
The presence of MCT1, MCT2, and LDH in neuronal
mitochondrial fractions was determined by standard Western
blotting techniques [13]. The antibodies to MCT1, MCT2, and
LDH were the same as described in the CLSM procedure. In
addition, identity of the mitochondrial fraction was confirmed by
probing for COX. Evaluation of contamination of the mitochon-
drial fraction by sarcolemmal remnants was done by probing with
rabbit anti-b1-Na
+-K
+-ATPase (Upstate Serologicals, Charlottes-
ville, VA), rabbit anti-GLUT1 (Santa Cruz), and F-actin (Abcam).
MagicMark XP Western Standard (Invitrogen, Grand Island, NY)
was used for molecular weight standards.
Results
Mitochondrial MCT1, MCT2, and LDH detected by
immunohistochemistry in rat brain tissues
MCT1 and MCT2 were detected by CLSM mainly in the
thalamus and hippocampus of rat brain tissues (Figs. 1–3). Fig. 1
shows the presence of MCT1, the mitochondrial marker COX,
and the neuronal marker MAP2 in rat thalamus. Comparing
staining for MCT1 (Fig. 1A) or COX (Fig. 1B) with MAP2
(Fig. 1C), it appears that MCT1 and mitochondria are abundant
in neurons. Furthermore, the superposition of the probes for
MCT1, COX, and MAP2 clearly shows colocalization of MCT1
with the mitochondrial reticulum of neurons (Fig. 1D). In addition
to the result with MCT1, we detected MCT2 in neurons of the rat
thalamus (Fig 2). There, superposition of probes for MCT2, COX,
and MAP2 also clearly shows mitochondrial MCT2 in neurons
Neuronal MCT & LDH
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at this larger magnification, the presence of MCT2 in the
mitochondrial reticulum of a neuron is evident (Fig. 3D).
To assess specificity of brain area LDH isoform expression, we
probed for LDH-M (as typically found in skeletal muscle) and
LDH-H (as typically found in heart) in the hippocampus, thalamus
and entorhinal and somatosensory rat cortex.
LDH-M protein expression was clearly detected in rat cortex
(Fig. 4B), and merged images indicated the pattern of LDH-M
localization to match that of the mitochondrial marker VDAC
(Fig. 5). On the other hand, LDH-H protein expression was clear
in neurons of the rat hippocampus (Fig. 4D). In the micrograph
with larger magnification, superposition of signals for LDH-H and
VDAC clearly showed LDH to colocalize with the mitochondrial
reticulum (white in Fig. 6D). In rat thalamus, signals for LDH-H
predominate (Fig. 4F), but a signal for LDH-M is also apparent
(Fig. 4C).
MCT1 and MCT2 are associated with COX in rat brain
tissue
In order to determine the subcellular localization and the
physical association between the various components of the ILS,
we performed immunocoprecipitation experiments on solubilized
mitochondrial fractions. Protein complexes in mitochondrial
fractions were pulled down with antibodies to either the
mitochondrial protein COX or normal IgG (nIgG) as a control,
and then probed for MCT1, MCT2, LDH and the plasma
membrane marker protein Na
+/K
+-ATPase (Fig. 7). COX
coprecipitated MCT1, MCT2, and to a lesser extent, LDH from
the mitochondrial fraction of rat brain tissue homogenates.
However, COX did not coprecipitate Na
+/K
+-ATPase. The
specificity of the complex composition was further demonstrated
by the absence of coprecipitation of these proteins with nIgG.
When isolating brain mitochondrial fractions, we avoided the use
Figure 1. Immunohistochemical images of rat brain cross-
sections demonstrating mitochondrial MCT1 in thalamic
neurons. When signals from probes for the lactate/pyruvate trans-
porter MCT1 (A, green) and mitochondrial cytochrome oxidase, COX (B,
red) were merged with those of the neuronal marker MAP2 (C, blue),
superposition of the signals (D, yellow/white) showed colocalization of
MCT1 and components of the mitochondrial reticulum in neurons
(white arrows). Scale bar=20 mm.
doi:10.1371/journal.pone.0002915.g001
Figure 2. Immunohistochemical images of rat brain cross-
sections demonstrating mitochondrial MCT2 in thalamic
neurons. When signals from probes for MCT2 (A, green), and
mitochondrial COX (B, red) were merged with those of the neuronal
marker MAP2 (C, blue), superposition of the signals (D, yellow/white)
showed colocalization of MCT2 and components of the mitochondrial
reticulum in neurons (white arrows). Scale bar=20 mm.
doi:10.1371/journal.pone.0002915.g002
Figure 3. Immunohistochemical images of rat brain cross-
sections demonstrating mitochondrial MCT2 in hippocampal
neurons. Superposition of signals from probes for MCT2 (A, green),
COX (B, red) and MAP2 (C, blue) showed clear colocalization (D, yellow/
white) in neurons. Scale bar=10 mm.
doi:10.1371/journal.pone.0002915.g003
Neuronal MCT & LDH
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COX and LDH such as proteases, detergents and Percoll
gradients [12,17,18]. Therefore, the mitochondrial fractions we
obtained from brain contained remnants of cytoskeleton and
plasma membrane constituents (such as Na
+-K
+-ATPase) that are
highly expressed in brain cells [18]. Separation of mitochondrial
reticulum remnants from non-mitochondrial cell constituents is
known to be difficult [19], but because the plasma membrane
marker Na
+-K
+-ATPase was not detected in immunoprecipitates,
contamination was unlikely to be a confounding factor in the
interpretation of results.
Mitochondrial MCT2 and LDH detected by
immunocytochemistry in rat brain primary cell cultures
Existence of an ANLS in vivo is controversial in the current
literature [20,21]. Part of the difficulty in evaluating presence of an
ANLS arises because of regional neuronal heterogeneity as well as
neuron-astroglia complexity, giving rise to observations of different
patterns of MCT expression in vivo and in vitro [22,23]. In an
attempt to resolve interpretation of previously observed differenc-
es, we assessed the expression patterns of mitochondrial MCT and
LDH isoforms in mixed neuron/glia primary cell cultures derived
from rat hippocampus as well as from cortex. Cultures were
enriched for neuronal development by use of the astrocyte
inhibitor cytosine-b-D-arabinofuranoside (Ara-C), with the result
Figure 4. Immunohistochemical images of rat brain cross-
sections showing area-specific expression of LDH-M (A–C) and
LDH-H (D–F). In hippocampus (A and D), signals for LDH-H
predominate (D, arrows) whereas a signal for LDH-M is not evident
(A). On the other hand, in cortex (B and E), signals for LDH-M
predominate (B, arrows), but a signal for LDH-H is not evident (E). In
thalamus (C and F), signals for LDH-H predominate (F, arrows), but a
signal for LDH-M is also apparent (C, arrow). Scale bar=200 mm.
doi:10.1371/journal.pone.0002915.g004
Figure 5. Immunohistochemical images of rat brain demon-
strating mitochondrial LDH-M in cortical neurons. When signals
from probes for LDH-M (B, red) and the mitochondrial protein VDAC (A,
green) were merged with those for the neuronal marker MAP2 (C, blue),
superposition of the signals (D, yellow/white) showed colocalization of
LDH-M and components of the mitochondrial reticulum. Scale
bar=20 mm.
doi:10.1371/journal.pone.0002915.g005
Figure 6. Immunohistochemical images of rat brain cross-
sections demonstrating mitochondrial LDH-H in hippocampal
neurons. Superposition of signals from probes for VDAC (A, green),
LDH-H (B, red) and MAP2 (C, blue) showed extensive colocalization
throughout the neuron (D, yellow/white). Scale bar=20 mm.
doi:10.1371/journal.pone.0002915.g006
Figure 7. Antibodies to COX and normal IgG (nIgG) were used
to develop immunoprecipitates (IP) from Tween 20 (1%)-
solubilized mitochondrial fractions of brain tissue. IP proteins
were subsequently probed with antibodies to MCT1, MCT2, LDH, and
b1-Na
+-K
+-ATPase. MCT1 and MCT2 were coprecipitated with COX, and
LDH was slightly, but significantly coprecipitated with COX as
compared to nIgG (no protein was coprecipitated with nIgG). The
plasma membrane marker b1-Na
+-K
+-ATPase was not coprecipitated
with either COX or nIgG. Sup, supernatant after immunoprecipitation in
lysates of mitochondrial fractions.
doi:10.1371/journal.pone.0002915.g007
Neuronal MCT & LDH
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astrocytes (data not shown). When data obtained on tissue sampled
in vivo and cultured cells were compared, differences were obtained
with regard to the expression of MCT1. Figure 8 shows the
presence of mitochondrial MCT2 in a neuronal cell cultured from
rat hippocampus. Similarly, neuronal MCT2 was detected in
primary cells of cortex (micrographs are not shown). However,
contrary to what was seen in cross-sections of adult rat brain
(Fig. 1), MCT1 was not evident in primary culture cells.
In addition to heterogeneity in the expression of mMCT1 and -
2, we also saw differences in the distribution of mLDH when data
obtained in vivo and in vitro were compared. Figure 9 shows the
presence of mitochondrial LDH in a cultured neuron labeled with
an antibody that recognizes all LDH isoforms. This result was
typical of cells obtained from rat hippocampus and cortex. When
isoform-specific antibodies were used, an antibody to LDH-M
stained neurons of the cortex, but the same antibody only faintly
stained neurons in the hippocampus. Those results suggest the
predominance of LDH-M in rat cortical neuron mitochondria,
and LDH-H in hippocampal neuron mitochondria. These latter
results and our interpretation of them correspond to localizations
seen in rat brain cross-sections (e.g., Fig. 4).
Mitochondrial outer membrane association with plasma
membrane Na
+-K
+-ATPase
Results of CLSM studies on adult brain sections clearly showed
LDH and MCT to colocalize with COX in mitochondria (Figs. 1–6).
However, to obtain information from an independent technique, we
probed primary enriched neuronal cultures. That procedure allowed
for improved purification of mitochondrial fractions. Figure 10 shows
immunoblots of mitochondrial fractions of cultured neuronal cells.
Recalling that COX coprecipitated MCT1, MCT2 and LDH, but
not Na
+-K
+-ATPase(Fig. 7),results in Fig. 10 are different in showing
that isolated mitochondria obtained from primary neuronal cell
cultures contained Na
+-K
+-ATPase. Consistent with recent results
obtained on an astrocytoma cell line [24], the non-mitochondrial
fraction markers GLUT1 and F-actin were not detected in
mitochondrial fractions from either cortical and hippocampal
primary culture cells (Fig. 10). Hence, rather than indicating
contamination, it may be that the Na
+-K
+-ATPase is associated with
the outer mitochondrial membrane [25]. In this way, the ATP system
necessary for maintaining plasma membrane cation gradients could
Figure 8. Immunohistochemical images demonstrating mito-
chondrial MCT2 in a cultured neuron from rat hippocampus.
Superposition of signals from probes for MCT2 (A, green), COX (B, red),
and MAP2 (C, blue) showed extensive colocalization (D, white) in a
cultured neuron. Scale bar=10 mm.
doi:10.1371/journal.pone.0002915.g008
Figure 9. Immunohistochemical images demonstrating mito-
chondrial LDH in neurons cultured from rat hippocampus and
cortex. Superposition of signals from probes for LDH (A, green), COX
(B, red) and MAP2 (C, blue) showed clear colocalization (D, yellow/
white) in neuron cells. Scale bar=10 mm.
doi:10.1371/journal.pone.0002915.g009
Figure 10. Immunoblots of mitochondrial fractions (MI) from
primary neuronal cultures developed from rat cortex and
hippocampus. Whole homogenates (WH) of the same cells were
loaded as positive controls. Mitochondria were immunoblotted using
plasma membrane markers for b1-Na
+-K
+-ATPase and GLUT1 as well as
the cytosol marker F-actin. Mitochondrial fractions (MI) showed the
presence of b1-Na
+-K
+-ATPase. However, while prominent in whole cell
homogenates (WH), the other plasma membrane marker Glut1 and the
cytosol marker F-actin were not apparent.
doi:10.1371/journal.pone.0002915.g010
Neuronal MCT & LDH
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homeostasis.
Interactions of COX and LDH detected by
immunocoprecipitation in rat brain primary cell cultures
To further explore the association between LDH and
mitochondrial proteins, we probed both isolated mitochondria
and COX immunoprecipitates for LDH. In contrast to normal
IgG, COX significantly coprecipitated LDH in mitochondrial
fractions from lysates of cells derived from cortical and
hippocampal areas (Fig. 11). We used a no-AraC control to
increase the relative abundance of astrocytes as occurs in vivo.
Consequently, our results cannot be interpreted to solely reflect
mLDH neuronal expression, as mLDH may be common to both
neurons and astrocytes. Such a conclusion is consistent with
recently reported results [24] showing that cells from a human
astrocytoma cell line contain mLDH.
Discussion
Potential importance of lactate for brain metabolism [7] and
glutamatergic signaling has been proposed [10]. However, the
presence of a mitochondrial lactate oxidation complex has not
previously been evaluated. Now, we provide data from adult brain
cross-sections and primary cell cultures supporting the presence of a
mitochondrial lactate oxidation complex (mLOC) in neurons. This
protein complex contains a lactate/pyruvate transport protein
(MCT1 or MCT2), LDH, and COX. The neuronal lactate
oxidation complex we observed would allow cerebral neurons to
take up and oxidize lactate regardless of the source of lactate
presentation (i.e., lactate from glycolysis in the same neuron or
adjacent astrocytes, or lactate delivered by the systemic circulation).
Accordingly, and consistent with the results of others [7,10,26], our
observations would permit operation of both Cell-Cell and
Intracellular Lactate Shuttles in brain. That such a functional
complex exists in vivo is consistent with studies on human patients
suffering traumatic brain injury (TBI). For instance, others [27,28]
have demonstrated that patients suffering moderate to severe TBI
achieved more favorable outcomes if they were capable of net brain
lactate uptake in comparison with patients demonstrating lactate
release, who experienced unfavorable outcomes. Similarly, it has
been demonstrated that the intravenous infusion of 100 mM L-
lactate improved cognitive recovery by preserving cerebral ATP
generation following TBI in rats [29].
One of the unique characteristics of neuronal lactate oxidation
complex is that MCT2 is a primary monocarboxylate transporter
in mitochondria, in contrast to skeletal muscle, in which MCT1 is
the sole mitochondrial monocarboxylate transporter [12,13]. The
prominent expression of MCT2 in neurons is probably relevant
physiologically. The lactate concentration in cerebral extracellular
fluid is typically ,1 mM [2,27–31], such that it makes sense that
the low-Km transporter isoform (MCT2: 0.7 mM) is preferred. On
the other hand, exclusive expression of MCT2 in the neuronal
lactate oxidation complex could be problematic because lactate
concentration in cerebral extracellular fluid can rise several-fold
(,3 mM) under physiological levels of neuronal hyperactivation
[20,27–31]. Hence, it makes sense that the mitochondrial lactate
oxidation complex in neurons benefits from expressing both
MCT1 and MCT2 isoforms. The Km for MCT1 (3.5 mM) is
higher than that of MCT2, so the presence of both MCT isoforms
could provide metabolic flexibility across the physiological range of
arterial and CSF lactate concentrations.
Equally important as the demonstration of mitochondrial
MCTs was that we also detected mitochondrial LDH in rat
neurons. Lactate oxidation to pyruvate is necessary to allow
neuronal mitochondria to utilize lactate as an energy source
[32,33]. Although it has been controversial for skeletal muscle [34–
36], several groups have recently provided independent evidence
that LDH is located in brain mitochondria and that those
mitochondria are capable of oxidizing lactate [24,33]. For
instance, Passarella and colleagues demonstrated functional lactate
oxidation by means of mitochondrial LDH in rat cerebellar
granule cells. Those results complement their previous observa-
tions of lactate oxidation by mitochondria from rat heart and liver
[33,37,38]. And, most recently, using electrophoretic and
immunohistochemical analyses,
13C-NMR, and HPLC, Lemire
et al. demonstrated that mitochondria in human astrocytoma cells
utilize LDH for lactate oxidation [24]. Here we showed for the
first time that LDH is located in mitochondria of neurons and
exists in association with COX and an MCT, both in vivo and in
vitro. Along with the results of previous studies, the findings of the
present study strongly suggest that the intracellular lactate shuttle
(ILS) is a significant carbohydrate metabolic system in brain
(especially neurons) as well as in muscles [1,35]. In this regard we
note that Schurr and Payne [39] demonstrated that malonate and
oxamate, two different LDH inhibitors, significantly suppressed
lactate-supported neuronal function, but did not inhibit pyruvate-
supported neuronal function in rat hippocampal slices. On that
basis they proposed a neuronal ILS [39].
The presence of a neuronal ILS [39] does not obviate the
presence of an ANLS because astrocytes also contain mitochon-
drial LDH and effectively oxidize lactate [24]. The contribution of
astrocytes to neuronal mitochondrial lactate consumption is
estimated to be approximately 15% [39]. However, we can
conclude that a neuronal ILS is a crucial metabolic system for
brain to carry out ANLS metabolism. Additionally, this ILS, based
Figure 11. To probe for an association between mitochondrial
cytochrome oxidase (COX) and lactate dehydrogenase (LDH),
antibodies to COX and normal IgG (nIgG) were used to develop
immunoprecipitates (IP) from Tween 20 (0.3%)-solubilized
mitochondrial fractions of cortex and hippocampus primary
cultures. Results were compared to those obtained on the supernatant
remaining after immunoprecipitation (Sup). COX and nIgG immuno-
precipitates were subsequently probed with an antibody that
recognized all LDH isoforms. Mitochondrial fractions (MI) were also
probed for LDH and results are presented as a positive control. LDH was
coprecipitated with COX as compared to nIgG (no protein was
coprecipitated with nIgG) in mitochondrial fractions derived from
cortical as well as hippocampal areas of rat primary cultures. When the
inhibitor to astrocyte development Ara-C was not used, COX
coprecipitated LDH in mitochondrial fractions from cortical and
hippocampal areas of rat primary cultures. Similar results obtained
with and without Ara-C (the lack of Ara-C facilitates development of
astrocytes among as neurons in cultures) indicate that astrocytes also
contain mLDH.
doi:10.1371/journal.pone.0002915.g011
Neuronal MCT & LDH
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role of mitochondrial redox in creating the proton and lactate
anion concentration gradients necessary for the oxidative disposal
of lactate in the mitochondrial reticulum in neurons, subsequently
providing neuroprotective effects against previously described
excitotoxicity [39,40].
Interestingly, distribution of LDH-M and LDH-H varied across
the brain. LDH-M is expressed prominently in the cortex, while
LDH-H is expressed strongly in the hippocampus. Because our
results differ somewhat from those expected on the basis of
previously reported studies assessing LDH mRNA expression by in
situ hybridization, where LDH-H mRNA was predominant in
cortex [41], it may be that regional LDH expression in the brain is
regulated post-transcriptionally.
The results of the present study cannot provide a physiological
explanation for the observed differences in regional distribution of
LDH isoforms. In skeletal muscle, white, fast-twitch glycolytic
fibers express mainly LDH-M and act as lactate producers, while
red, slow oxidative muscle fibers express significantly more LDH-
H and act as lactate consumers [6]. Hence, along with differences
in mitochondrial content, fast white and slow red fibers establish
the lactate concentration gradient allowing the Cell-Cell Lactate
Shuttle to operate in muscle tissue. However, in the brain, cells in
both cortex and hippocampus contain elaborate mitochondrial
networks and are metabolically active [42]. The presence of
mLDH is necessary to accomplish the first step in lactate
oxidation, but the specific isoform present appears to be of
secondary importance and tracks that expressed in the specific
tissue or cell type under consideration. For example, the heart is
typically a net lactate consumer and contains the LDH-H isoform.
However, the liver—typically also a net lactate consumer—
contains mostly the isoform prominent in white skeletal muscle,
LDH-M. As well, mitochondria of astrocytes contain LDH-H and
effectively oxidize lactate [24], but the ANLS posits that astrocytes
release lactate for oxidation in neurons. Consequently, for the
present, we consider the existence of both LDH-M and LDH-H
isoforms in neuronal mitochondria to permit both sensitivity and
metabolic flexibility of shuttling in response to changing lactate
levels. By these means, astrocytes may oxidize lactate generated
from glycolysis or they may release lactate for consumption by
neurons. As well, irrespective of an ANLS, both astrocytes and
neurons may utilize lactate provided form the systemic circulation
when arterial [lactate] rises as occurs under exercise [9] and other
stresses [27].
In summary, we provide evidence supporting the concept of
lactate shuttling within neurons and between neurons and glia.
Others have established that lactate uptake and oxidation are
characteristics of intact brains, brain slices, and isolated cells and
mitochondria. In the present report, we show how cerebral and
neuronal lactate uptake and oxidation might occur. As it does in
skeletal muscle, it is possible that the mitochondrial reticulum in
neurons establishes the concentration gradients allowing intrace-
rebral use of lactate as an energy source. The presence of an
mLOC in neurons would similarly establish the concentration
gradients allowing for cell-cell lactate exchange and permitting use
of vascularly delivered lactate. Along with our own previous results
as well as those of others showing lactate oxidation in vivo,i t
appears that the present results support generality of the utility of
lactate shuttling in energy-substrate exchange and metabolic
signaling [35]. These findings may encourage development of new
approaches to support nutrient delivery to a stunned brain
following trauma.
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